Clinical Trial Update: Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ecopipam versus placebo in adults with Childhood-Onset Fluency Disorder (stuttering) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood-onset Fluency Disorder

Drugs mentioned

• Ecopipam (Ecopipam)

Snippet

Sponsor: Emalex Biosciences Inc. | Conditions: Childhood-Onset Fluency Disorder (Stuttering) | Phase 2 | Status: COMPLETED